Editorial Policies

Focus and Scope

CURRENT ONCOLOGY

Aims & Scope

Current Oncology will publish:

Original Contributions: Peer reviewed, investigations that represent new and significant contributions to the field.

Review Articles: Reviews of major areas or sub-areas in the field of oncology. These articles may be of any length and are peer reviewed.

Editorials: Views of invited authors on a specific topic where they are recognized experts.

Controversies and Hypotheses

Clinical guidelines and consensus statements

Short Communications: These should be no longer than six double-spaced typewritten pages, including key references.

Letters to the Editor: Comments on papers published in Current Oncology or on any other matters of interest to oncology. These should not be more than two pages long (including the literature) and their publication is based only on the decision of the Editor, who occasionally asks experts on the merit of the contents.

Oncology Literature: An in-depth literature search of English bibliographies on topics related to oncology.

Book Reviews: As solicited by the Editorial Office.

Announcements of Forthcoming Meetings: Providing notice of forthcoming meetings, course offerings, and other events relevant to oncology.

  • All correspondence should be directed to the Editor-in-Chief:
    Dr. Michael McLean, Princess Margaret Hospital, 610 University Ave., Toronto, ON, M5G2M9, Canada
    Mike.McLean@rmp.uhn.on.ca
  • In some instances, specific questions may be more conveniently dealt with by a telephone call than by a letter. The telephone number of the Editorial Office is 416-946-2132.
  • Authors should submit manuscripts, figures, and tables electronically to: www.current-oncology.com Instructions on how to create an account and submit a paper are available via a powerpoint tutorial posted on the home page.
  • Authors are invited to submit the names and addresses of five or six individuals, who could, in their opinion, expertly review their manuscripts. The Editors, however, reserve the right to choose all reviewers.

 

Section Policies

Editorials

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

In Memoriam

Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Guest Editorials

Unchecked Open Submissions Unchecked Indexed Unchecked Peer Reviewed

Short Communication

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Letters to the Editor

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Integrative Therapies

Checked Open Submissions Unchecked Indexed Unchecked Peer Reviewed

Practice Guidelines

Checked Open Submissions Unchecked Indexed Unchecked Peer Reviewed

Medical

Checked Open Submissions Unchecked Indexed Unchecked Peer Reviewed

Book/Media Reviews

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Canadian Centre Activities

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Cancer Rehabilitation and Survivorship

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Chemotherapy Supplement

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Ethics

Checked Open Submissions Unchecked Indexed Unchecked Peer Reviewed

Medical Physics

Checked Open Submissions Unchecked Indexed Unchecked Peer Reviewed

Nutrition

Checked Open Submissions Unchecked Indexed Unchecked Peer Reviewed

Oncologic History

Checked Open Submissions Checked Indexed Unchecked Peer Reviewed

Pathology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Radiation

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Surgical

Checked Open Submissions Unchecked Indexed Unchecked Peer Reviewed

Third World Practice

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Updates and Developments in Oncology

Editors
  • Richard Ablin
  • Phil Gold
Unchecked Open Submissions Checked Indexed Unchecked Peer Reviewed

Urological

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Opinion

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Meeting Report

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Pediatric

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Translational

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Basic Research in Cancer

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Biomarkers in Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Case Report

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Guest Info-Editorial

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Meeting/Conference Abstracts

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Medical Imaging

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Drug Development in Contemporary Oncology

Editors
  • Michel Tremblay
Unchecked Open Submissions Checked Indexed Checked Peer Reviewed

Biomedical Ethics

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Cancer Genetics

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Nursing

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Palliative Care

Checked Open Submissions Checked Indexed Checked Peer Reviewed

Psychosocial Oncology

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Publication Frequency

Bimonthly, plus supplements

 

Open Access Policy

This journal provides open access to all of its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Such access is associated with increased readership and increased citation of an author's work. For more information on this approach, see the Public Knowledge Project, which has designed this system to improve the scholarly and public quality of research, and which freely distributes the journal system as well as other software to support the open access publishing of scholarly resources.

 

Archiving

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...

 

Welcome

Established in 1994, Current Oncology is a Canadian based and internationally distributed journal. Published bi-monthly plus special supplemental issues, Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease.

Original articles and review articles are invited for consideration for publication, and are selected by our international Editorial Board. For further information, please select the manuscript submission link.

Current Oncology is indexed in PubMed, Embase (Excerpta Medica Database), Scopus, Journal Selector, Crossref, DOAJ, and Emcare. It is also available in the databases of 100 libraries worldwide. Current Oncology is published by Multimed Inc.

 

Online Advertising Policy

Current Oncology accepts advertising and sponsorship for its website and e-mail service according to the following principles:



  1. All advertisements are subject to approval of Current Oncology, which reserves the right to reject or cancel any advertisement at any time.

  2. Current Oncology’s advertising sales representatives have neither control over, nor prior knowledge of, specific editorial content before it is published.

  3. Advertisers have no control or influence over the results of searches a user may conduct on the Current Oncology website. Search results are based solely on the functionality available through our search software (e.g., keywords or natural language) and user-defined criteria (e.g., displaying most recent or most relevant items first).

  4. Current Oncology does not release personally identifiable data on the users of our websites or e-mail service to advertisers.

  5. Online advertisers may receive reports that show aggregated data about response to their advertisements, including the number of ad impressions and the number of times an advertisement was clicked on.

  6. Advertiser links to other websites cannot prevent a user from easily returning to the Current Oncology website.

  7. Alcoholic beverages and tobacco products will not be advertised.

  8. Advertisements may not include offers for free merchandise or contests.

  9. All advertisements must be clearly germane to the practice of medicine.

  10. All advertisements must clearly and prominently identify the advertiser by trademark or signature.

  11. Advertising that appears on the Current Oncology website must be clearly distinguishable from editorial content.

  12. Advertising copy must be factual and in good taste.

  13. All advertisements are accepted and published by Current Oncology on the warranty of the agency and advertiser that both are authorized to publish the entire contents and subject matter of the advertisement.

  14. In consideration of publication of an advertisement, the advertiser and the agency, jointly and severally, agree to indemnify and hold harmless Current Oncology, its officers, agents and employees against expenses (including legal fees) and losses resulting from the publication of the contents of the advertisement, including, without limitation, claims or suits for libel, violation of privacy, copyright infringement, or plagiarism.

  15. Any advertising for the promotion of Current Oncology and the Current Oncology website will be clearly identified and point only to the feature advertised.


 Policy on Recruitment Advertisements



  1. All advertisements for employment must be nondiscriminatory and comply with all applicable laws and regulations. Ads that discriminate against applicants based on sex, age, race, religion, marital status, or physical handicap will not be accepted.

  2. International recruitment advertisers are required to confirm in writing that they are an equal opportunity employer.


Current Oncology’s Online Advertising Policy and Types of AdvertisingGenerally acceptable for consideration

Pharmaceutical products; medical-equipment products and services; medical software; practice-management products and services (including office equipment and supplies, medical billing systems, medical software products) and medical web sites.

Generally acceptable for consideration with certain conditions

Calls for patients to participate in clinical trials, or clinical-trial matching services: considered solely if the trial is conducted by a recognized academic institution.

All types of advertising not described above will be reviewed on a case-by-case basis.

Advertisers, media buyers, and others with specific questions about advertising acceptability should contact 905-975-2456 or email current_oncology@multi-med.com

 

Submit a Manuscript
 
Submit a Manuscript

*Advertisement for Current Oncology

 

Copyright © 2009 by Multimed Inc.
Current Oncology. ISSN: 1198-0052
Last Updated: 15/09/08